Another IPO is coming into the primary markets for listing. This time, the IPO belongs to the pharma & biotech sector.
It is the Biotech company named Codexis which has plans to come out with the IPO. The purpose is to raise somewhere around 100 million dollars, from the IPO or initial Public offering. The shares of type common stock will be sold through the IPO of Codexis.
No details are available about the price of share of Codexis IPO. No details are given about the number of shares being offered. The IPO from Codexis is in the initial phase.
The underwriters for the IPO issue are big names: Credit Suisse, Goldman Sachs, Piper Jaffray, RBC Capital Markets and Thomas Weisel Partners LLC. The valuations of Codexis and other details of listing date and price of the Codexis IPO will be intimated at a later date. The draft prospectus for the IPO has been filed by the company to the SEC or Securities and Exchange Commission of the USA.
The ticker symbol used by Codexis will be "CDXS".
| Watch out more for the Codexis IPO! | Table of Contents |
No comments:
Post a Comment